Could CSL stock be a millionaire-maker at $261

Does the exceptional biotech company still harness the power to make an investment today worth a million in the future?

| More on:
A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Those fortunate enough to have invested $10,000 in Altium Limited (ASX: ALU) over 11 years ago are now sitting on a holding worth more than $1 million. However, investors today might hope to find a millionaire-maker in a more established part of the stock market, such as CSL Limited (ASX: CSL).

The biotechnology giant is no stranger to generating enormous returns for its shareholders either. Since November 2012, the share price of the plasma products maker has risen 442% — exceeding the S&P/ASX 200 Index (ASX: XJO) by a mountainous 386%.

It makes one wonder… could CSL shares be a way of achieving the millionaire milestone without the violent ups and downs?

Going big on a blue-chip

It goes without saying $1 million is a tonne of money. To obtain such a large sum, one usually needs to invest a handsome amount from the outset. Even with $10,000 of hard-earned cash, a 10,000% increase (100 times) return is required to reach a million dollarydoos.

In 2022, the average savings for a man between 30 and 49 years of age was $27,005. Meanwhile, the average savings for a woman of the same age bracket came in at $24,081.

This would imply that even if someone were to plough all their savings (~$25,000) into one stock — which is not advisable — a million dollars remains a 40-fold increase away. It might be a tall order, but it's not out of the realm of possibilities.

In the last 20 years, there have been 10 ASX-listed companies that have experienced a share price increase greater than 4,000%, including:

  • Objective Corporation Ltd (ASX: OCL) – 4,159%
  • Webjet Limited (ASX: WEB) – 5,103%
  • Australian Ethical Investment Ltd (ASX: AEF)

The question then becomes, can the CSL stock price achieve this feat from here?

What would be needed?

Today, CSL shares are fetching $261 apiece. A 40-fold return would see the CSL stock price reach $10,440 — assuming it didn't undergo any stock splits.

This alone doesn't really mean much. Instead, the company's market capitalisation is far more tangible.

The vaccine and drug company is currently valued at $124.1 billion. As such, a millionaire-creating CSL market cap would be $4,964 billion. For context, the most valuable listed company in the world right now is Apple Inc (NASDAQ: APPL) at $4,448 billion.

Assuming CSL traded on a price-to-earnings (P/E) ratio comparable to Apple (31 times), the biotech company would need to produce $160 billion in after-tax earnings if it reached a similar value. That would mean CSL's earnings need to grow nearly 73 times greater than its $2.194 billion in FY2023.

Can CSL stock deliver?

The largest listed pharmaceutical company in the world at present is Eli Lilly and Co (NYSE: LLY). In the latest trailing 12-month period, this behemoth generated nearly US$5 billion in profits.

It's hard to imagine a future where CSL makes 32 times more than the biggest pharma company globally.

Never say never… but investing is a game of probabilities — and I'd say the odds of the CSL stock price increasing 40-fold from here are slim.

In fact, despite its already meteoric run, I'd pick Altium over CSL to be another 40-bagger from here.

Why? Two reasons… the law of large numbers and the remaining runway for growth. As a PCB design software provider, Altium may still have vast opportunities ahead as the world continues to integrate digital components into more items.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the 'five best ASX stocks' for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now...

See The 5 Stocks *Returns as of 30 April 2025

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Altium, Australian Ethical Investment, CSL, and Objective. The Motley Fool Australia has recommended Australian Ethical Investment, CSL, and Objective. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

A man and woman sit next to each other looking at each other and feeling excited and surprised after reading good news about their shares on a laptop.
Opinions

Where I'd invest in ASX shares after the RBA interest rate cut

These stocks look really attractive to me. Here’s why…

Read more »

Miner looking at a tablet.
Opinions

3 reasons why the Fortescue share price could still be a buy

Let’s dig into why this mining giant could be a solid buy.

Read more »

A young woman wearing a red and white striped t-shirt puts her hand to her chin and looks sideways as she wonders whether to buy NAB shares
Opinions

The pros and cons of buying Wesfarmers shares in May

Is this retail giant an appealing opportunity?

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Opinions

2 ASX 200 shares that I think are still bargains after the market rally

These businesses look like attractive opportunities. Here’s why…

Read more »

A young woman looks at something on her laptop, wondering what will come next.
Opinions

Worried about another stock market sell-off?

Market declines don’t need to be too scary.

Read more »

An evening shot of a busy Times Square in New York.
Opinions

The pros and cons of buying US-focused ASX ETFs in the current environment

In a short amount of time, the US share market has erased the declines that it went through at the…

Read more »

I young woman takes a bite out of a burrito n the street outside a Mexican fast-food establishment.
Opinions

Time to cash in your gains? Brokers say sell on these 3 ASX 200 shares

Experts say these stocks are overvalued and it may be time to take some profits off the table.

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
Opinions

Here's what I'd do after the big ASX stock market rally

The US and China are working towards a trade deal.

Read more »